BMP2 Regulates Osterix through Msx2 and Runx2 during Osteoblast Differentiation
2008 · Journal of Biological Chemistry · 521 citations
https://doi.org/10.1074/jbc.m801774200
T
Toshiyuki Yoneda
University of Occupational and Environmental Health Japan(JP)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
345
Papers
21.8K
Citations
84
h-index
176
i10-index
Toshiyuki Yoneda is an academic researcher from University of Occupational and Environmental Health Japan. The author has contributed to research in topics: Bone health and treatments & Bone Metabolism and Diseases & Radiopharmaceutical Chemistry and Applications. The author has an h-index of 84, co-authored 294 publications.
ORCID: 0000-0002-3214-5656Papers by this author
worksAntiresorptive agent-related osteonecrosis of the jaw: Position Paper 2017 of the Japanese Allied Committee on Osteonecrosis of the Jaw
2016 · Journal of Bone and Mineral Metabolism · 295 citations
https://doi.org/10.1007/s00774-016-0810-7
Tumor-derived platelet-derived growth factor-BB plays a critical role in osteosclerotic bone metastasis in an animal model of human breast cancer.
2002 · PubMed · 173 citations
Effect of denosumab on Japanese patients with rheumatoid arthritis: a dose–response study of AMG 162 (Denosumab) in patients with RheumatoId arthritis on methotrexate to Validate inhibitory effect on bone Erosion (DRIVE)—a 12-month, multicentre, randomised, double-blind, placebo-controlled, phase II clinical trial
2016 · Annals of the Rheumatic Diseases · 162 citations
https://doi.org/10.1136/annrheumdis-2015-208052
Effects of the anti-RANKL antibody denosumab on joint structural damage in patients with rheumatoid arthritis treated with conventional synthetic disease-modifying antirheumatic drugs (DESIRABLE study): a randomised, double-blind, placebo-controlled phase 3 trial
2019 · Annals of the Rheumatic Diseases · 134 citations
https://doi.org/10.1136/annrheumdis-2018-214827
Retinoic acid regulates commitment of undifferentiated mesenchymal stem cells into osteoblasts and adipocytes
2012 · Journal of Bone and Mineral Metabolism · 57 citations
https://doi.org/10.1007/s00774-012-0385-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat